EUVIMEDEUVIMED entdecken
Crossref

Self-Illuminating Nanoagonist Simultaneously Induces Dual Cell Death Pathways via Death Receptor Clustering for Cancer Therapy

Yuchan You, Luwen Zhu, Yanling Song, Jiahao Hu, Minjiang Chen, Jucong Zhang, Xinyi Xu, Xiajie Huang, Xiaochuan Wu iD, Jingyi Lu, Xiangmin Tong, Jian-Song Ji iD und 1 weitere

ACS Nano · 2024

DOI: 10.1021/acsnano.4c03767 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2024. Verfasst von Yuchan You und 12 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, P. R. China. Hauptthemen laut MEDLINE: Receptors, TNF-Related Apoptosis-Inducing Ligand, Nanoparticles. Die Arbeit nennt 49 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, TNF-Related Apoptosis-Inducing LigandNanoparticlesHumansAnimalsMiceApoptosisTumor MicroenvironmentAntineoplastic AgentsCell Line, TumorCell DeathNeoplasmsHydrogen PeroxidePeptides

Stichwörter der Autor:innen

cancer immunotherapydeath receptorphoto-cross-linkingreceptor clusteringself-illuminating nanoparticle

Substanzen

Receptors, TNF-Related Apoptosis-Inducing LigandAntineoplastic AgentsHydrogen PeroxidePeptides

Autor:innen und Institutionen

  • College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, P. R. China.
  • Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research, Lishui Central Hospital and Fifth Affiliated Hospital of Wenzhou Medical College, 289 Kuocang Road, Lishui 323000, P. R. China.
  • Department of Hematology, the Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, Hangzhou 310006, P. R. China.
  • Innovation Center of Transformational Pharmacy, Jinhua Institute of Zhejiang University, Jinhua 321299, P. R. China.

ORCID-Profile: Xiaochuan Wu, Jian-Song Ji, Yong-Zhong Du

Förderung

  • National Key Research and Development Program of China
  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

You, Y., Zhu, L., Song, Y., Hu, J., Chen, M., Zhang, J., Xu, X., Huang, X., Wu, X., Lu, J., Tong, X., Ji, J. S., & Du, Y. Z. (2024). Self-Illuminating Nanoagonist Simultaneously Induces Dual Cell Death Pathways via Death Receptor Clustering for Cancer Therapy. ACS Nano. https://doi.org/10.1021/acsnano.4c03767

Vancouver

You Y, Zhu L, Song Y, Hu J, Chen M, Zhang J, et al. Self-Illuminating Nanoagonist Simultaneously Induces Dual Cell Death Pathways via Death Receptor Clustering for Cancer Therapy. ACS Nano. 2024. doi:10.1021/acsnano.4c03767

BibTeX
@article{You2024,
  author = {You, Yuchan and Zhu, Luwen and Song, Yanling and Hu, Jiahao and Chen, Minjiang and Zhang, Jucong and Xu, Xinyi and Huang, Xiajie and Wu, Xiaochuan and Lu, Jingyi and Tong, Xiangmin and Ji, Jian-Song and Du, Yong-Zhong},
  title = {Self-Illuminating Nanoagonist Simultaneously Induces Dual Cell Death Pathways via Death Receptor Clustering for Cancer Therapy},
  journal = {ACS Nano},
  year = {2024},
  doi = {10.1021/acsnano.4c03767}
}
Kostenlos starten →